Brett Sandercock - 15 Aug 2024 Form 4 Insider Report for RESMED INC (RMD)

Role: Chief Financial Officer
Signature: Brett Sandercock, Chief Financial Officer
Issuer symbol: RMD
Transactions as of: 15 Aug 2024
Transactions value $: $0
Form type: 4
Filing time: 16 Aug 2024, 10:21:32 UTC
Previous filing: 12 Aug 2024
Next filing: 10 Sep 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RMD	ResMed Common Stock	Award	$0	+7.92K	+8.89%	$0.00	97K	15 Aug 2024	Direct	F1
transaction	RMD	ResMed Common Stock	Award	$0	+841	+0.87%	$0.00	97.8K	15 Aug 2024	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met. Stock unitsvest1/3each year on the anniversary of the grant.
F2	Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met for this portion ofthegrant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.

Content

Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met for this portion ofthegrant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.